Pharmacological and toxicological activities of α-humulene and its isomers: A systematic review

GM de Lacerda Leite, M de Oliveira Barbosa… - Trends in Food Science …, 2021 - Elsevier
Sesquiterpernes are natural compounds widely distributed in plants rich in essential oils;
among these compounds, α-humulene and its isomers stand out for their multiple …

m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD

F Xu, X Huang, Y Li, Y Chen, L Lin - Molecular Therapy-Nucleic Acids, 2021 - cell.com
Lung adenocarcinoma (LUAD) is the most frequent subtype of lung cancer worldwide.
However, the survival rate of LUAD patients remains low. N6-methyladenosine (m 6 A) and …

TNFR1 and TNFR2, which link NF-κB activation, drive lung cancer progression, cell dedifferentiation, and metastasis

G Shi, Y Hu - Cancers, 2023 - mdpi.com
Simple Summary This review discusses new findings for the roles of TNFR1 and TNFR2 in
the development of aggressive lung squamous cell carcinoma and lung adenocarcinoma by …

PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer

GC Shin, HM Lee, N Kim, SU Seo, KP Kim… - … & Molecular Medicine, 2024 - nature.com
Tumor necrosis factor superfamily (TNFSF) resistance contributes to the development and
progression of tumors and resistance to various cancer therapies. Tumor-intrinsic alterations …

Tumor necrosis factor α: Taking a personalized road in cancer therapy

A Ben-Baruch - Frontiers in Immunology, 2022 - frontiersin.org
The potent pro-inflammatory cytokine tumor necrosis factor α (TNFα) has been connected to
cancer progression and treatment ever since its discovery as a major factor contributing to …

Serum cytokines and neutrophil-to-lymphocyte ratio as predictive biomarkers of benefit from PD-1 inhibitors in gastric cancer

Y Hou, X Li, Y Yang, H Shi, S Wang, M Gao - Frontiers in immunology, 2023 - frontiersin.org
Background Immunotherapy is significantly revolutionizing cancer treatment and
demonstrating promising efficacy in gastric cancer (GC) patients. However, only a subset of …

The mystery of titan hunter: Rationalized striking of the MAPK pathway via Newly synthesized 6‐Indolylpyridone‐3‐Carbonitrile derivatives

MM Saleh, T El-Moselhy, E El-Bastawissy… - European Journal of …, 2023 - Elsevier
MAPK pathway sparkles with RTK activation, passes through subsequent downstream RAS-
RAF-MEK-ERK signaling cascades, with consequent direct and indirect CDK4/6 signaling …

Integrated circulating tumour DNA and cytokine analysis for therapy monitoring of ALK-rearranged lung adenocarcinoma

AK Angeles, F Janke, AK Daum, M Reck… - British Journal of …, 2023 - nature.com
Background Detection of circulating tumour DNA (ctDNA) in biological fluids is a minimally
invasive alternative to tissue biopsy for therapy monitoring. Cytokines are released in the …

Integrated network pharmacology, molecular docking, molecular simulation, and in vitro validation revealed the bioactive components in soy-fermented food products …

AEO Elkhalifa, H Banu, MI Khan, SA Ashraf - Nutrients, 2023 - mdpi.com
Globally, lung cancer remains one of the leading causes of cancer-related mortality,
warranting the exploration of novel and effective therapeutic approaches. Soy-fermented …

Primary and acquired resistance against immune check inhibitors in non-small cell lung cancer

Q Sun, X Wei, Z Wang, Y Zhu, W Zhao, Y Dong - Cancers, 2022 - mdpi.com
Simple Summary NSCLC accounts for approximately 84% of lung malignancies and the
clinical application of ICIs provides a novel and promising strategy. However, approximately …